Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children. - Wikidata - awgldk - TriplyDB

Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children.

Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children.

http://www.wikidata.org/entity/Q34659232

about

Long-term Outcomes of Childhood Onset Nephrotic Syndrome American Society of Nephrology quiz and questionnaire 2013: glomerulonephritis.Long-term prognosis of 4 children with steroid-sensitive nephrotic syndrome and relapse after 30 years of age.Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report.Rituximab for troublesome cases of childhood nephrotic syndrome.A series of patients with minimal change nephropathy treated with rituximab during adolescence and adulthood.Long-term results of children diagnosed with idiopathic nephrotic syndrome; single center experience Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial.Single dose of rituximab in children with steroid-dependent minimal change nephrotic syndrome.Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome Tubular B7-1 expression parallels proteinuria levels, but not clinical outcomes in adult minimal change disease patients.Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol.The influence of gender and sexual hormones on incidence and outcome of chronic kidney disease.Recurrent focal segmental glomerulosclerosis: a discrete clinical entity.Childhood nephrotic syndrome in the 21st century: What's new?Regulatory T cells and minimal change nephropathy: in the midst of a complex network.Methylprednisolone pulse therapy and intravenous cyclophosphamide therapy combined with cocktail therapy in severe pediatric Henoch-Schönlein purpura nephritis patient.Remission of nephrotic syndrome diminishes urinary plasmin content and abolishes activation of ENaC.Nephrotic syndrome in infants and children: pathophysiology and management.The amino acid mutations of the podocin in proteinuria: a meta-analysis.Long-term repeated rituximab treatment for childhood steroid-dependent nephrotic syndrome.Glomerular Filtration Rate Trends During Follow-up in Children With Steroid-Sensitive Nephrotic Syndrome.Study on Steroid Induced Ocular Findings in Children with Nephrotic Syndrome REducing STEroids in Relapsing Nephrotic syndrome: the RESTERN study- protocol of a national, double-blind, randomised, placebo-controlled, non-inferiority intervention study.Relationship between Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphism and Susceptibility of Minimal Change Nephrotic Syndrome: A Meta-Analysis.Second-line options for refractory steroid-sensitive and -resistant nephrotic syndrome.Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome.Body weight-based prednisolone versus body surface area-based prednisolone regimen for induction of remission in children with nephrotic syndrome: a randomized, open-label, equivalence clinical trial.The problem of transition from pediatric to adult healthcare in patients with steroid-sensitive nephrotic syndrome (SSNS): a survey of the experts.Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?Tacrolimus for children with refractory nephrotic syndrome: a one-year prospective, multicenter, and open-label study of Tacrobell®, a generic formula.Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy.Rituximab for Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome in Adults: A Retrospective, Multicenter Study in Spain.

P2860

Q26744025-D62EF359-DCB4-403F-9DAD-DE69462C0937 Q33571864-6D04D85B-310D-46A9-9998-EFC102AA8904 Q33622129-BAB14ADB-6D63-4FF3-BB5D-D8A8BA0A0C0B Q34362680-870A6D97-2A59-42E3-BED7-6C779CB357FD Q34683518-47BB15EB-FD06-4802-AB72-9CF235F11368 Q35674857-AC4A6AC8-71A1-4995-9189-4EBF2790F8F2 Q35712990-85F0D333-9CCA-4044-9D62-9B3EC2135163 Q36003160-C4F32798-2860-4C32-B1D9-16D5ED55E449 Q37108328-10998DCA-26A5-4B35-97C4-9917B5064E8D Q37275486-CCD86214-00F7-40AA-B136-FA603D95F95D Q37620681-FDA289B6-D121-48B0-9A63-A22B5C414A2D Q37728395-27C49A24-9390-4419-A48C-F10E63A138A0 Q37902094-BE5D1436-D943-4ABB-9A97-76B0EDDBFE72 Q37979793-18E045BD-261D-4AAD-8CE0-CB97F68CB817 Q38255356-0B057CF6-5DED-44AF-A78C-496D450ADC68 Q38543132-762C00F4-69E5-457A-A3BE-F7D75B982109 Q38783714-DB2CCDEF-AEAF-4AD9-9280-D242D4419C41 Q39179542-944D1751-36B2-403F-AD62-3187E4F5A4D2 Q40039238-BD6E2554-04AF-4C12-A9F8-F071E3CBADAB Q40695800-E512E647-759E-4796-A26E-BDB87C5B1175 Q41387077-E8085257-2FD1-4177-827C-3682656FE895 Q41808307-81643C74-52C2-41DF-83F9-DC1E8DC0B190 Q41874959-7CC3D211-32A9-4DE8-8E29-B2A8B96CDBE9 Q41906685-F4CEEC1F-5AA1-430F-88E3-EE437AF9F063 Q42032380-9011DDAA-9AE4-485A-BAA8-5EB7694F32CE Q42723614-6C6830DC-0DDA-4360-AD07-4EFCB6B2A40A Q46912071-B21318B2-9D11-44DB-8A84-32F6C0523719 Q47333560-9EF84880-1C92-4114-A8E2-5103F4315A72 Q50726719-0D1C55E0-5BB0-4E53-8C6C-AC650121F1FD Q50856119-8C02D246-A5EA-4234-9235-871875C03FDB Q51292313-F93C95D0-A2C8-49D1-9F64-2CB25FE10E58 Q53625850-1FFBFE60-A75A-4144-A20E-AD96272886AA Q53838634-12735649-9C33-4AE6-A883-0E44D85D280C

P2860

Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children.

http://www.wikidata.org/entity/Q34659232

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Long-term outcome of biopsy-pr ...... ephrotic syndrome in children.

@ast

Long-term outcome of biopsy-pr ...... ephrotic syndrome in children.

@en

Long-term outcome of biopsy-pr ...... ephrotic syndrome in children.

@nl

type

label

Long-term outcome of biopsy-pr ...... ephrotic syndrome in children.

@ast

Long-term outcome of biopsy-pr ...... ephrotic syndrome in children.

@en

Long-term outcome of biopsy-pr ...... ephrotic syndrome in children.

@nl

prefLabel

Long-term outcome of biopsy-pr ...... ephrotic syndrome in children.

@ast

Long-term outcome of biopsy-pr ...... ephrotic syndrome in children.

@en

Long-term outcome of biopsy-pr ...... ephrotic syndrome in children.

@nl

P1433

Q34659232-85769145-4854-47C8-94E9-6A70889F0095

P1476

Q34659232-4C9F5ED3-7566-4B46-8368-2D416A16716C

P2093

Q34659232-103A8E40-1495-47F3-AA4E-8C74F5AF9035

Q34659232-30347A38-C5AA-4662-9529-C8BD51E8992C

Q34659232-32014DB2-33E3-41E0-8439-F0DE48CD88EB

Q34659232-33861DF4-CE42-43E4-BB4A-9EF1026677A1

Q34659232-40C6D9E3-2F7E-4885-8476-47F515C7313F

Q34659232-555A6331-CD1B-4128-A8A3-7E88251A5CA0

Q34659232-5D28857D-9C2A-4513-BB72-9D56C68B446F

Q34659232-989DA52F-4D37-4BB8-960B-14E86AB9DAE1

Q34659232-A817E0AE-FD70-4D08-B1BE-2D0B66C86FA8

P2860

Q34659232-03608E91-23AE-42B0-A76D-12A9F3447A35

Q34659232-0F42BBA1-D31A-4BFF-931C-FF992DEE9299

Q34659232-10268AA4-1388-45A2-A50E-C60375720658

Q34659232-146E634F-BD2E-44EB-B122-9FBE94437A5E

Q34659232-1CD297A8-81D9-437D-9657-4B8986557C82

Q34659232-217E192F-3B18-4A33-84D3-CE267D1EE51D

Q34659232-25D9FCF8-6324-4CB9-A93A-2C658F70FED7

Q34659232-2868126B-CE30-447D-BBB7-D10D9392D182

Q34659232-3D0BD671-1F65-4281-A973-99197CBB3B66

Q34659232-44B5E740-379B-47D9-BBC2-6EC1173508C3

P304

Q34659232-6F7845C5-FF19-4BBA-8E3F-A0849C99D913

P31

Q34659232-20DF0C69-1D00-4589-9B60-A74565ED99CA

P356

Q34659232-AA0801D2-D9FE-4A83-B84B-9673E16E73C8

P433

Q34659232-9FFA136E-750F-4F3E-8074-2E3C4D91BD28

P478

Q34659232-B0BE70E7-AFAA-492E-A244-E9BCF500BF9B

P50

Q34659232-CD41CC3E-20F2-4E0D-AB89-3FA6E972FC77

P577

Q34659232-CCD094F1-E198-45B6-A88B-1DE9FC853B17

P698

Q34659232-1EF70429-BBDB-4182-B99F-33B72E90960F

P932

Q34659232-A3AC491C-84F6-4D7F-92F5-84022564B6E6

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Long-term outcome of biopsy-pr ...... ephrotic syndrome in children.

@en

P2093

Bert L P van den Heuvel

http://www.w3.org/2001/XMLSchema#string

Elena N Levtchenko

http://www.w3.org/2001/XMLSchema#string

Hans R M Cruysberg

http://www.w3.org/2001/XMLSchema#string

Henriette A C Kyrieleis

http://www.w3.org/2001/XMLSchema#string

Ilse Pronk

http://www.w3.org/2001/XMLSchema#string

Jack F M Wetzels

http://www.w3.org/2001/XMLSchema#string

Jan A M Kremer

http://www.w3.org/2001/XMLSchema#string

Marije M Löwik

http://www.w3.org/2001/XMLSchema#string

Wim J G Oyen

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations

NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele

Specific activation of the glucocorticoid receptor and modulation of signal transduction pathways in human lens epithelial cells

Potassium channel and NKCC cotransporter involvement in ocular refractive control mechanisms

Prediction of creatinine clearance from serum creatinine

Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee

Effects of dexamethasone on human lens epithelial cells in culture.

Ocular complications of topical, peri-ocular, and systemic corticosteroids.

A formula to estimate the approximate surface area if height and weight be known. 1916.

Mutation spectrum in the nephrin gene (NPHS1) in congenital nephrotic syndrome.

P304

1593-1600

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.05691108

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-09-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19808243

http://www.w3.org/2001/XMLSchema#string

P932

2758253

http://www.w3.org/2001/XMLSchema#string